FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317148511> ?p ?o ?g. }

• W2317148511 endingPage "A314" @default.
• W2317148511 startingPage "A314.2" @default.
• W2317148511 abstract "<h3>Background</h3> Systemic onset juvenile idiopathic arthritis (SoJIA) and adult onset still disease (AoSD) are unlicensed indications for anakinra. Although safety has been reported to be good, increase of liver enzymes have been noted in four SoJIA patients^1,2,3 and we have recently described acute hepatitis in two patients with AoSD^4,5. <h3>Methods</h3> The charts of six patients with SoJIA (n=3, ILAR criteria) and AoSD (n=3, Yamaguchi criteria) who developed acute hepatitis during anakinra treatment were retrospectively studied. Strength of association between liver injury and the medication was assessed through the Roussel-Uclaf Causality Assessment Method⁶. <h3>Results</h3> All patients were female taking anakinra for 27 days (range 21-39) at hepatitis diagnosis. Cytolysis was variable (aspartate aminotransferase: 1041UI/L (range 336-2386), alanine aminotransferase (ASAT): 2647 UI/L (range 568-3346)), cholestasis was moderate compared to cytolysis (alkaline phosphatase (ALP): 262UI/L (range 71-376), total bilirubin 94UI/L (range 17-171) Gamma-glutamyl transpeptidase 397UI/L (range 62-538)) with ALAT/ALP ratio >5 in all cases (range 7-13). Factor V amount were systematically >100%. One patient had vomiting, the others were asymptomatic, and none had clinical evidence of SoJIA or AoSD activity. Median CRP, ferritin and polynuclear count were respectively 0.8mg/dL (range 0.1-7.0), 409µg/L (range77-3108) and 4170/mm3 (range 1500-10650). Non-drug related causes were systematically researched. Acute viral infection were excluded in all patients by serology (VHA, VHB, VHC, (n=6), VHE (n=5), HSV 1&2 (n=6), EBV (n=6), CMV (n=4)) but one patient had detectable EBV genome (2450 copies/ml). None patient tested positive for anti-smooth muscle, anti-mitochondria, anti-LKM1, anti-SLA or anti-liver cytosol antibodies. When tested (n=4), cupremia and ceruloplasmin were normal. Abdominal ultrasound revealed moderate hepatomegaly in one patient and no abnormalities in the others. Four patients underwent liver biopsy that did not show autoimmune hepatitis or hemophagocytosis but nonspecific hepatitis. Withdrawal of anakinra, made 4 days after the diagnosis of hepatitis (range 1-27), was followed by liver enzymes normalisation in all patients (time to reaction 3.5 days (range 1-56); time to 50% improvement 26 days (range 4-64)). Co-treatments with a compatible latency and that were also withdrawn were omeprazole (n=2), dalteparin (n=1), tetrazepam (n=1). When anakinra was re-administrated (n=2), hepatitis relapsed. According to the Roussel-Uclaf Causality Assessment Method, anakinra was the definite cause of hepatitis (score>8) in two patients and the probable cause (score 6-8) in the four others. <h3>Conclusions</h3> In SoJIA and AoSD patients treated with anakinra, liver enzymes should be monitored as this treatment might cause acute cytolytic hepatitis. <h3>References</h3> Quartier et al. Ann Rheum Dis. 2011; 70:747-54. Nigrovic PA et al. Arthritis Rheum. 2011; 63:545-55. Canna et al. Pediatr Rheumatol Online J. 2009;7:21 Meyer et al. Congrès de la Société francaise deRhumatologie. Paris: Elsevier; 2011. A264. Diallo et al. Rev Med Interne. 2012 [Epub]. Danan and Benichou. J. Clin. Epidemiol. 1993; 46:1323–1330. <h3>Disclosure of Interest</h3> None Declared" @default.
• W2317148511 created "2016-06-24" @default.
• W2317148511 creator A5001077644 @default.
• W2317148511 creator A5001817383 @default.
• W2317148511 creator A5016589479 @default.
• W2317148511 creator A5026946329 @default.
• W2317148511 creator A5034623450 @default.
• W2317148511 creator A5036816060 @default.
• W2317148511 creator A5037847620 @default.
• W2317148511 creator A5041077575 @default.
• W2317148511 creator A5052230550 @default.
• W2317148511 creator A5056168650 @default.
• W2317148511 creator A5068916735 @default.
• W2317148511 creator A5080881858 @default.
• W2317148511 creator A5087386909 @default.
• W2317148511 creator A5091885715 @default.
• W2317148511 date "2013-06-01" @default.
• W2317148511 modified "2023-09-23" @default.
• W2317148511 title "THU0443 Anakinra Might Cause Acute Hepatitis in Patients with Systemic Onset Juvenile Idiopathic Arthritis and Adult Onset Still Disease" @default.
• W2317148511 doi "https://doi.org/10.1136/annrheumdis-2013-eular.971" @default.
• W2317148511 hasPublicationYear "2013" @default.
• W2317148511 type Work @default.
• W2317148511 sameAs 2317148511 @default.
• W2317148511 citedByCount "0" @default.
• W2317148511 crossrefType "journal-article" @default.
• W2317148511 hasAuthorship W2317148511A5001077644 @default.
• W2317148511 hasAuthorship W2317148511A5001817383 @default.
• W2317148511 hasAuthorship W2317148511A5016589479 @default.
• W2317148511 hasAuthorship W2317148511A5026946329 @default.
• W2317148511 hasAuthorship W2317148511A5034623450 @default.
• W2317148511 hasAuthorship W2317148511A5036816060 @default.
• W2317148511 hasAuthorship W2317148511A5037847620 @default.
• W2317148511 hasAuthorship W2317148511A5041077575 @default.
• W2317148511 hasAuthorship W2317148511A5052230550 @default.
• W2317148511 hasAuthorship W2317148511A5056168650 @default.
• W2317148511 hasAuthorship W2317148511A5068916735 @default.
• W2317148511 hasAuthorship W2317148511A5080881858 @default.
• W2317148511 hasAuthorship W2317148511A5087386909 @default.
• W2317148511 hasAuthorship W2317148511A5091885715 @default.
• W2317148511 hasConcept C126322002 @default.
• W2317148511 hasConcept C203014093 @default.
• W2317148511 hasConcept C2776029263 @default.
• W2317148511 hasConcept C2777077863 @default.
• W2317148511 hasConcept C2777910003 @default.
• W2317148511 hasConcept C2778593092 @default.
• W2317148511 hasConcept C2778606649 @default.
• W2317148511 hasConcept C2779134260 @default.
• W2317148511 hasConcept C2780567839 @default.
• W2317148511 hasConcept C2781228260 @default.
• W2317148511 hasConcept C71924100 @default.
• W2317148511 hasConcept C90924648 @default.
• W2317148511 hasConceptScore W2317148511C126322002 @default.
• W2317148511 hasConceptScore W2317148511C203014093 @default.
• W2317148511 hasConceptScore W2317148511C2776029263 @default.
• W2317148511 hasConceptScore W2317148511C2777077863 @default.
• W2317148511 hasConceptScore W2317148511C2777910003 @default.
• W2317148511 hasConceptScore W2317148511C2778593092 @default.
• W2317148511 hasConceptScore W2317148511C2778606649 @default.
• W2317148511 hasConceptScore W2317148511C2779134260 @default.
• W2317148511 hasConceptScore W2317148511C2780567839 @default.
• W2317148511 hasConceptScore W2317148511C2781228260 @default.
• W2317148511 hasConceptScore W2317148511C71924100 @default.
• W2317148511 hasConceptScore W2317148511C90924648 @default.
• W2317148511 hasIssue "Suppl 3" @default.
• W2317148511 hasLocation W23171485111 @default.
• W2317148511 hasOpenAccess W2317148511 @default.
• W2317148511 hasPrimaryLocation W23171485111 @default.
• W2317148511 hasRelatedWork W1972417423 @default.
• W2317148511 hasRelatedWork W2065690519 @default.
• W2317148511 hasRelatedWork W2078688345 @default.
• W2317148511 hasRelatedWork W2164272509 @default.
• W2317148511 hasRelatedWork W2317148511 @default.
• W2317148511 hasRelatedWork W2405084215 @default.
• W2317148511 hasRelatedWork W2488369687 @default.
• W2317148511 hasRelatedWork W2587981553 @default.
• W2317148511 hasRelatedWork W2912327950 @default.
• W2317148511 hasRelatedWork W1768943615 @default.
• W2317148511 hasVolume "72" @default.
• W2317148511 isParatext "false" @default.
• W2317148511 isRetracted "false" @default.
• W2317148511 magId "2317148511" @default.
• W2317148511 workType "article" @default.